Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients?

@article{Velema2012ShouldAA,
  title={Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients?},
  author={M. Velema and Bibi H B Kwa and W. de Ronde},
  journal={Current Opinion in Pulmonary Medicine},
  year={2012},
  volume={18},
  pages={118–124}
}
  • M. Velema, Bibi H B Kwa, W. de Ronde
  • Published 2012
  • Medicine
  • Current Opinion in Pulmonary Medicine
  • Purpose of review Chronic obstructive pulmonary disease (COPD) is a widespread disease with high morbidity rates. Advanced stages can be complicated by unintentional weight loss and muscle wasting, which may contribute to increased morbidity and mortality. Reversal of weight loss increases muscle strength and exercise capacity and improves survival. This can partly be achieved by nutritional support, preferably combined with increase in exercise. Androgenic anabolic steroids (AASs), of which… CONTINUE READING
    17 Citations
    Musculoskeletal Disorders in Chronic Obstructive Pulmonary Disease
    • 58
    • PDF
    Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness
    • 6
    • PDF
    Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-Analysis
    • 117
    • PDF
    Sex Differences in Muscle Wasting.
    • 56

    References

    SHOWING 1-10 OF 43 REFERENCES
    Therapeutic effects of anabolic androgenic steroids on chronic diseases associated with muscle wasting
    • 22
    Anabolic steroids in COPD: a review and preliminary results of a randomized trial
    • 42
    Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease.
    • 338
    • PDF